A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

In an interview with Peers & Perspectives in Oncology, Michael S. Leapman, MD, MHS, discusses the significance of a 10-year ...

ROACH: I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL ...

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...

Although prostate cancer screening has been embraced by ... screen-detected cancers would be of low stage (T1c), low grade (Gleason score <7), and associated with low PSA levels (<10 ng/ml ...

This study shows that in Geneva, the concordance between the GSs of biopsy and those of prostatectomy is moderate, and lies within the current standards. Our study also confirms that a lower ...

"BREAKING: Head of the Israeli Prime Minister's Medical Team: Netanyahu has been diagnosed with Grade 3 prostate cancer," the X post reads. The Instagram post was liked more than 5,000 times in ...

To estimate grade misclassification, we evaluated the incidence of Gleason upgrading among patients with GG1 ... institution retrospective analysis to identify patients with GG1 prostate cancer on ...

Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...